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Abstract We have previously shown that the rat PCNA
(proliferating cell nuclear antigen) gene promoter is responsive
to serum stimulation. In this study, the sequence of the promoter
responsive to serum stimulation has been localized in the region
between nucleotides 370 and +125 relative to the transcription
initiation site. This region contains an ATF site (nucleotides 351
to 344) and an AP-1 site (nucleotides 364 to 358). Mutation at
either the ATF or the AP-1 site reduced the serum responsiveness
of the promoter. In gel mobility shift assays, nuclear extracts
from serum stimulated cells, compared to those from quiescent
cells, exhibit an increasing binding activity toward a promoter
related oligonucleotide (370 to342) which includes the ATF site
and the AP-1 site. Formation of the DNA:protein complexes
requires the simultaneous involvement of ATF and AP-1 sites as
either element can abrogate the complexes in the competition
experiment. Both the distance and sequence are essential to
complex formation. Moreover, ATF-1 but not ATF-2 (or CREB)
has been identified as a major component of the complexes in the
antibody supershift or interference experiment. The results of
this study suggest that ATF-1 in association with other factors is
involved in regulating the serum stimulation of the rat PCNA
promoter activity via the proximal ATF and AP-1 sites.
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1. Introduction
Proliferating cell nuclear antigen (PCNA) is a protein factor
required for DNA synthesis and DNA repair [1^5]. In addi-
tion to its known interactions with components of the DNA
replication machinery (i.e. DNA polymerase N and replication
factor C), PCNA has been found to interact directly with
various proteins which are involved in cell cycle progression,
DNA repair and other functions [6] including cyclin D/cyclin
D dependent kinase [7], p21Waf1 (a CDK inhibitor) [8],
Gadd45 (a UV inducible protein) [9], and MyD118 (a di¡er-
entiation primary response transcription factor) [10]. These
interactions suggest the expression of PCNA as a potential
target in the control of cell proliferation, di¡erentiation, apop-
tosis and senescence. Previous studies on the regulation of
PCNA gene expression have indicated that the expression of
PCNA is dependent on mRNA level and is growth regulated
[11^13]. Although the level of PCNA mRNA may be regu-
lated post-transcriptionally [14], the induction of human
PCNA gene expression by adenovirus E1A as well as the
serum stimulation of rat PCNA gene expression are controlled
at the transcriptional level [15,16]. In addition, the promoter
of the human PCNA gene is solely responsible for the failure
of gene expression in G1 arrested cells [17]. Promoters of the
mammalian PCNA genes are TATA-less with a cluster of GC
boxes in the region between nucleotides 3300 and 3100 rel-
ative to the transcription initiation site [15,16,18,19]. The full
promoter activity is approximately within the 200 bp up-
stream of the +1 site. The E1A responsive region of the hu-
man PCNA promoter is localized in the 85 nucleotide region
upstream of the +1 site. Furthermore, the integrity of the
ATF/CRE site (nucleotides 352 to 345) of the promoter is
crucial to E1A induction [20]. The same ATF/CRE site is also
present in the corresponding regions of rodent PCNA pro-
moters. Previously we have observed that the rat PCNA pro-
moter is responsive to serum stimulation [16]. In this report,
the region of the promoter responsive to serum stimulation
has been identi¢ed and the importance of the proximal ATF/
CRE site and its immediately upstream AP-1 site have been
shown. Our data suggest that ATF-1 in association with other
factors is involved in regulating the serum stimulation of the
rat PCNA promoter activity via the proximal ATF site and
the AP-1 site.
2. Materials and methods
2.1. Cell culture
Rat glioma (9L) cells and Chinese hamster ovary cells were pro-
vided by the American Type Culture Collection and cultured in Ea-
gle’s minimum essential medium and McCoy’s 5A medium, respec-
tively. Cells were routinely maintained in media containing 10% fetal
bovine serum (FBS) at 37‡C in 5% CO2.
2.2. Plasmids
The rat PCNA promoter plasmid, 3693CAT (nucleotides 3693 to
+125, previously referred to as D6), was prepared as described in [16].
Two PCNA promoters of shorter length at the 5P end (3240 to +125,
and 370 to +125, respectively) were obtained by the PCR method
using 3693CAT as the template. They are referred to herein as
3240CAT and 370CAT. The site-speci¢c mutations of the rat
PCNA promoter 3240CAT at ATF site (351 to 344) and AP-1
(364 to 358) sites were obtained by megaprimer PCR [21] using
mutated primers 5P-AGGTTGTGCATATGCAGCGCTGACC-3P
and 5P-GGTGGGTCATATGGCGCTGTGACGC-3P, respectively.
To facilitate the identi¢cation, the original ATF (TGACGCCA) and
AP-1 (TGGGTCA) sites were replaced with the restriction enzyme
NdeI recognition site (CATATG). Mutations of the promoter were
veri¢ed by DNA sequencing analyses. All the promoters were sub-
cloned in the vector of pBasic-CAT (Promega Co.) in such a way that
the reporter gene chloramphenicol acetyltransferase (CAT) was driven
by the promoters.
2.3. DNA transfection
Transient transfection of PCNA promoters into 9L cells was per-
formed using the DEAE-dextran method and the CAT assay was used
to measure the promoter activity as described previously [16]. To
avoid dish-to-dish variation of transfection e⁄ciency, the strategy
FEBS 21298 21-12-98
0014-5793/98/$19.00 ß 1998 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 8 ) 0 1 5 4 9 - X
*Corresponding author. Fax: (886) (3) 571-5934.
E-mail: lslyc@life.nthu.edu.tw
FEBS 21298FEBS Letters 441 (1998) 200^204
described in [23] was used, i.e. to transfect large cells and then to
trypsinize the cells after 24 h of incubation and distribute them among
smaller dishes. Furthermore, in the transient expression experiments,
we used the protein amount to normalize the CAT activity, for con-
ventional promoters such as pCMV-L-gal have been shown to be
serum responsive and promoters non-responsive to serum stimulation
were not available to us. Nonetheless, we made e¡orts to minimize the
weight of transfection e⁄ciency variation in our data, by repeating the
same experiment for 5^6 times. For obtaining stable transfectants of
the promoters, cells were co-transfected with the promoters and
pCMV-Neo, a plasmid conferring neomycin (G418) resistance on
cells. Cells that survived in the presence of antibiotic were pooled
together as mixed clones for experiments.
2.4. Preparation of nuclear extracts
CHO.K1 cells at 70^80% con£uence were serum-starved for 48 h to
reach quiescence. The quiescent cells were divided into two parts: one
part of cells was continuously grown in serum-free medium and the
other part of cells was cultured in medium with 10% FBS. The cells
were harvested at the indicated time for nuclear preparation according
to the procedure described in [22], except that an additional centrifu-
gation step (30 000 rpm for 10 min) was adopted to clarify the nuclear
extracts.
2.5. Electrophoretic mobility shift assay (EMSA)
2.5.1. Probe preparation and labeling. The oligonucleotides were
prepared by synthesizer. The sense strand and the antisense strand
were annealed in annealing bu¡er (10 mM Tris pH 8.0, 100 mM
NaCl, 1 mM EDTA) by the following procedure with a thermal
cycler: 2 min at 88‡C, 10 min at 65‡C, 10 min at 37‡C, and then 5
min at 25‡C. The oligonucleotides were labeled by Klenow reaction or
kinase reaction as described in [23]. The labeled probes were gel-pu-
ri¢ed prior to use.
2.5.2. EMSA. The DNA binding assays were performed in
1UEMSA bu¡er consisting of 12 mM HEPES (pH 7.6), 50 mM
NaCl, 1 mM DTT and 5% (v/v) glycerol. DNA probes (V20 000
cpm) were added to 20 Wl binding reactions containing 5^10 Wg of
nuclear extracts and 1.5 Wg poly(dI-dC)-poly(dI-dC). The incubations
were conducted at 4‡C for 15 min following a 20 min pre-incubation
at the same temperature in the absence of probe. For supershift or
antibody interference assay, antibodies were added to the binding
reaction 1 h prior to the addition of the probe. All antibodies were
obtained from Santa Cruz Biotechnology, Inc. They were antibodies
to ATF-1 (sc-243x), to ATF-2 (sc-187x), to c-jun/AP-1 (sc-44x) and to
c-fos (sc-413x). DNA:protein complexes were resolved on 0.4 mm
thick 5% polyacrylamide (29:1 Bis)-0.5UTBE gels. Gel electrophore-
sis was preformed in the cold room at 10 V/cm without bu¡er re-
circulation. The gels after separation were dried and exposed to X-ray
¢lms at 370‡C with intensifying screens.
3. Results and discussion
3.1. Serum responsiveness of the rat PCNA promoter is
localized in the region between nucleotides 370 and +125
Previously we showed that the rat PCNA promoter (nucleo-
tides 3693 to +125) is responsive to serum stimulation [16].
To localize the region responsive to serum stimulation, we
used promoters with variable deletions at the 5P region for
the study. Deletion of the 5P sequence did not signi¢cantly
a¡ect the basal activity of the promoter unless it went over
nucleotide 3240 (see Fig. 1A). The shortest promoter
370CAT has only about 40% of the full activity. Nonetheless,
serum responsiveness was observed with the promoters even
for 370CAT. The activity of the promoter increases during
the course of serum stimulation (Fig. 1B). The promoter
370CAT contains AP-1 (nucleotides 364 to 358) and
ATF/CRE (nucleotides 351 to 344) consensus sites. The
ATF/CRE site and its immediately upstream sequence are
fairly conserved among the mammalian PCNA promoters
[20]. The respective region in human PCNA promoter is re-
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Fig. 1. A: Relative activities of the rat PCNA promoters with varia-
ble 5P ends. Rat glioma (9L) cells were transiently transfected with
a PCNA promoter as described previously [16]. Cell extracts were
prepared and assayed for CAT enzyme activity at 46 h post trans-
fection. B: Serum responsiveness of the rat PCNA promoters with
variable 5P ends. Cells (9L) were transiently transfected with a
PCNA promoter as mentioned in A and recovered for 2 days in se-
rum-free medium to become quiescent. Cells were then grown in se-
rum-containing (b) or serum-free (a) medium and harvested at the
indicated period for CAT activity assay. The change of the pro-
moter activity during the time course is shown by the relative level
to that at time zero. The activity at time zero was set at 1. The var-
iation of transfection e⁄ciency was controlled by the strategy as de-
scribed in Section 2. Data are presented from at least three inde-
pendent experiments, and the standard error bars are indicated.
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sponsible for E1A activation [19]. In order to investigate if the
region of the rat PCNA promoter is important to serum stim-
ulation, we constructed promoters with site-directed muta-
tions at either the ATF/CRE (351 to 344) or the AP-1
(364 to 358) site. For convenience, these mutant promoters
are referred to as mATF and mAP-1, respectively.
3.2. Serum responsiveness of the rat PCNA promoter involves
the proximal ATF/CRE and AP-1 sites
Typical results of the promoter activity assays are shown
in Fig. 2A, indicating that both mutant promoters have
lower basal activity than the wild type, and particularly the
mAP-1 is notably weak. Hence, the ATF/CRE and the AP-1
sites are important to the basal activity of the promoter. Fur-
thermore, serum responsiveness is signi¢cantly reduced in
both mATF and mAP-1 as compared to the wild type (see
Fig. 2B), indicating that the integrity of the ATF/CRE and
AP-1 sites is crucial to the serum responsiveness of the pro-
moter.
3.3. Serum stimulation increases the binding activity in nuclear
extract toward the rat PCNA promoter related
oligonucleotide
To study the nature of the regulatory proteins which mod-
ulate the promoter activity, we performed EMSAs. The DNA
probe in the EMSA experiments was an oligonucleotide con-
taining the promoter sequence between nucleotides 370 and
342, which includes both the AP-1 and the ATF sites. Results
of a typical EMSA experiment are shown in Fig. 3, indicating
that formation of speci¢c DNA:protein complexes is in-
creased due to serum stimulation (compare lanes 2 and 4 or
lanes 3 and 5). Furthermore, complex formation was abro-
gated in the presence of either ATF or AP-1 oligomers (lanes
6 and 7), suggesting that complex formation involves simulta-
neously ATF and AP-1 sites, i.e. the regulatory proteins form
co-complexes with these two sites. As the two sites are rela-
tively close to each other (6 bases apart), it is of interest to
know if the distance or the sequence between the two sites is
essential to complex formation. For this purpose, we per-
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Fig. 2. E¡ects of mutations of the ATF and AP-1 sites on serum responsiveness of the rat PCNA promoters. CHO.K1 stable transfectants of
wild type or mutant rat PCNA promoters were serum-starved for 2 days and then serum-stimulated again for the indicated interval before har-
vest for the CAT assay. A: Typical results of a CAT analysis. Each CAT activity assay contained a constant amount of crude extract. The in-
tervals (6, 12, 18 etc.) are in hours. B: Serum responsiveness of the wild type and mutant PCNA promoters. The change of activity for each
promoter during the time course is shown by the relative level to that at time zero. The activity at time zero was set at 1. Data are presented
from at least three independent experiments, and the standard error bars are indicated.
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formed EMSA experiments with two mutant oligonucleotides
as DNA probes. One of these mutant probes is referred to as
del-space in which the sequence between AP-1 and ATF was
shortened; the other is referred to as alt-space in which the
sequence was altered while the distance remained the same
(see Fig. 4A). Results of a typical experiment are shown in
Fig. 4B (lanes 2^4), indicating that each mutant oligonucleo-
tide gives similar but distinct patterns as compared to that of
the wild type oligonucleotide. Seven complexes (1^7) were
identi¢ed with the wild type probe, while only four complexes
(2^5) were seen with the alt-space probe. In addition, with the
alt-space probe, the formation of the DNA:protein complexes
was apparently less e¡ective (compare lanes 3 and 2 in Fig.
4B). On the other hand, with the del-space probe, two distinct
complexes (* and **) were detected. Furthermore, some of the
common complexes may be slightly enhanced with the del-
space probe. Nevertheless, both alt-space and del-space lost
the ability to form complex 1. Taken together, the data sug-
gest that both the distance and the sequence of the space are
essential to complex formation.
For identifying the protein components in the EMSA com-
plexes, several antibodies of choice were included in the bind-
ing reaction mixture for antibody interference or supershift
assays. In the presence of ATF-1 antibody (lane 6 of Fig.
4B), the complexes 3 and 4 were clearly supershifted, indicat-
ing that ATF-1 is a major component of the complexes. In
contrast to ATF-1, c-jun (or c-fos) is apparently not a major
component in the complexes as the antibody to c-jun (or c-
fos) only interfered with the formation of complex 1. While
the ATF site may be recognized by dimers of various mem-
bers of the ATF family or the CREB family, other members
of the families such as ATF-2 or CREB were not detected in
the complexes (data not shown). Furthermore, the complexes
were totally abrogated when the nuclear extracts were pre-
treated with phosphatase (data not shown), suggesting that
phosphorylation of the transcription factors is critical to the
serum stimulation of the rat PCNA promoter. Consistent with
this ¢nding is the observation that the activity of the promoter
was induced in the presence of okadaic acid, a phosphatase
inhibitor (unpublished results). At the moment, our experien-
ces suggest that serum stimulation of the promoter involves
the signal transduction pathways which lead to the phospho-
rylation of ATF-1 (and other associated factors). However,
ATF-1 or related transcription factors may be phosphorylated
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Fig. 3. EMSA of nuclear protein:rat PCNA promoter related oligo-
nucleotide complexes. The nuclear extracts (NE) used in lanes 2 and
3 were obtained from quiescent (G0) cells and those used in lanes
4^7 were obtained from serum-stimulated (10 h) cells. Nuclear ex-
tract used in lanes 2 and 4 was 5 Wg, while in lanes 3 and 5^7 it
was 10 Wg. No nuclear extract was added in lane 1. The rat PCNA
promoter related oligonucleotide (372 to 342, see Fig. 4A) was
32P-labeled. Lanes 6 and 7 contained excess cold ATF oligomer (5P-
CAGCGCTGTGACGCCACAACC-3P) and AP-1 oligomer (5P-
CGCTTGATGACTCAGCCGAA-3P), respectively. The speci¢c
DNA:protein complexes are indicated by brackets.
Fig. 4. E¡ects of alterations of space sequence between the ATF
(351 to 344) and the AP-1 (364 to 358) sites on the formation of
rat PCNA promoter related oligonucleotide:nuclear protein com-
plexes. A: Promoter related probes: wt, oligonucleotide with the
wild type space sequence (GCGCTG); alt-space, oligonucleotide
with an altered space sequence (ATATCA); del-space, oligonucleo-
tide with a deleted space sequence (CCG). Only the sequences of
the sense strands are shown. B: EMSA using wild type (wt), alt-
space (alt) or del-space (del) oligonucleotides as probes. The nuclear
extract (NE) used in lane 1 was obtained from quiescent (G0) cells
and those used in lanes 2^7 were obtained from serum-stimulated
(10 h) cells. Antibodies to c-jun (lane 5), ATF-1 (lane 6) or c-fos
(lane 7) were included in the binding reactions with the wild type
probe. Free probes in the gel are not shown. Two distinct com-
plexes formed by the del-space probe are indicated by * and **.
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by various protein kinases including cAMP-dependent protein
kinase [24], Ca2/calmodulin-dependent protein kinase [25]
and mitogen-activated protein kinases [26,27]. Each protein
kinase represents a di¡erent signaling pathway. Hence, iden-
ti¢cation of the protein kinase leading to the activation of the
rat PCNA promoter will be carried out in the future. As in the
rat PCNA promoter, the ATF site of the human PCNA pro-
moter is essential to E1A activation and ATF-1 is a major
component of the PCNA-E1A responsive element protein
complexes [28]. The resemblance suggests that E1A activation
and serum stimulation may share common signaling path-
ways. However, a recent study has found that CREB but
not ATF-1 was able to mediate transactivation of a minimal
PCNA-CAT by E1A [29]. Hence, the role of ATF-1 in the
regulation of the human (and rat) PCNA promoter activity
should be further investigated.
In conclusion, we report herein the study on the cis- and
trans-acting elements that may be involved in the serum stim-
ulation of the rat PCNA promoter. The feature of serum
responsiveness is localized in the region between bases 370
and +125, and the proximal ATF and AP-1 sites in this region
are essential to both the basal activity and serum stimulation
of the rat PCNA promoter. These two sites appear to cross-
talk as either ATF or AP-1 oligomers was able to abrogate
the whole DNA binding complex. To the best of our knowl-
edge, this phenomenon is the ¢rst to be reported. In addition,
we have not identi¢ed a case similar to the rat PCNA pro-
moter that possesses both ATF and AP-1 sites in the vicinity.
Based upon our data, we hypothesize that ATF-1 and its
associated factors require the integrity of the ATF site and
its immediately upstream AP-1 for transactivating the rat
PCNA promoter in response to serum stimulation.
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